CORONA Remedies Secures ANVISA GMP Certification for Bhayla Facility
Corona Remedies Ltd 路 Press Release 路 23 Oct 2026, 12:12 am
CORONA Remedies Secures ANVISA GMP Certification for Bhayla Facility CORONA Remedies received Good Manufacturing Practice (GMP) certification from Brazil's ANVISA on 22nd Oct'26 for its Bhayla, Ahmedabad facility, covering Oral Solid Dosage and Women's Hormone production lines. This marks the company's third major global GMP clearance, complementing existing EU-GMP and EAEU-GMP accreditations. While India remains its core market driving over 96% of revenue, the approval facilitates strategic expansion into Brazil's estimated USD 44 billion pharmaceutical market.
Original exchange filing (PDF)
More announcements from Corona Remedies Ltd
- Intimation of Participation in Analyst / Investor Conference 路 16 Nov 2026
- Intimation of Participation in Analyst / Investor Conference 路 07 Nov 2026
- Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the second quarter and half year ended September 30, 2026 路 05 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 04 Nov 2026
- Audio Recording of Q2H1FY27 Earnings Conference Call with Analysts / Investors 路 02 Nov 2026
- Intimation for Analyst / Investor Meet 路 31 Oct 2026
- Analyst / Investor Presentation 路 31 Oct 2026
- Press Release on Financial Results for second quarter and half year ended on September 30, 2026 路 31 Oct 2026
